Asia Pacific Electrocardiograph (ECG) Market Size to register a growth of 7.8% CAGR

14-03-2018 | Report Format: Electronic (PDF)

Growth, Trends and Report Highlights

According to a new report Asia Pacific Electrocardiograph (ECG) Market, published by KBV research, the Asia Pacific Electrocardiograph (ECG) Market Size would witness market growth of 7.8% CAGR during the forecast period (2017 - 2023).

The Japan market dominated the Asia Pacific Holter Monitors Market by Country in 2016, and would continue to be a dominant market till 2023, growing at a CAGR of 6.3 % during the forecast period. The India market is expected to witness a CAGR of 13.6% during (2017 - 2023).

The Wireless ECG Systems market dominated the in 2016, and would continue to be a dominant market till 2023. The Portable ECG Systems market is expected to witness a CAGR of 10.7% during (2017 - 2023).

The Hospitals & Clinics market dominated the Asia Pacific Electrocardiograph (ECG) Market by End User in 2016, and would continue to be a dominant market till 2023; thereby, achieving a market value of $7.2 million by 2023. The Other End Users market is expected to witness a CAGR of 10.4% during (2017 - 2023).

The 3-6 Lead ECG market dominated the India Electrocardiograph (ECG) Market by Lead Type in 2016, and would continue to be a dominant market till 2023growing at a CAGR of 11.8 % during the forecast period.

Full Report: https://www.kbvresearch.com/asia-pacific-electrocardiograph-ecg-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the countries in the region. The key impacting factors of the Asia-Pacific Electrocardiograph (ECG) Market have been discussed in the report with the elaborated company profiles of Compumed, Bionet, Mindray Medical International Limited, General Electric (GE) (GE Healthcare), Koninklijke Philips N.V (Philips Healthcare), Schiller AG, Welch Allyn, Nihon Kohden Corporation, Medtronic, and Opto Circuits Limited.